Back
Luvu Brands Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
40
LUVU
Luvu Brands
Last Price:
$0.06
Seasonality Move:
15.21%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$99.80
Seasonality Move:
6.73%
Sell
40
Luvu Brands (LUVU)
is a Sell
Is Luvu Brands a Buy, Sell or Hold?
-
The current Luvu Brands [LUVU] share price is $0.06. The Score for LUVU is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
LUVU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LUVU Stock Price Chart
What is Luvu Brands's stock price today?
-
The Luvu Brands share price today is $0.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LUVU is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $100.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
LUVU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 52.91 | Buy |
Chaikin Money Flow: | -28421 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.22 | Sell |
Relative Strength Index (14 RSI): | 38.38 | Sell |
Chaikin Money Flow: | 544784 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LUVU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.06 | Sell |
20-day SMA: | 0.05 | Buy |
50-day SMA: | 0.05 | Buy |
200-day SMA: | 0.06 | Sell |
8-day EMA: | 0.06 | Sell |
20-day EMA: | 0.06 | Buy |
50-day EMA: | 0.05 | Buy |
200-day EMA: | 0.06 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.91 | Sell |
20-day SMA: | 106.68 | Sell |
50-day SMA: | 114.29 | Sell |
200-day SMA: | 126.68 | Sell |
8-day EMA: | 104.06 | Sell |
20-day EMA: | 106.89 | Sell |
50-day EMA: | 112.29 | Sell |
200-day EMA: | 121 | Sell |
Luvu Brands Earnings Growth & LUVU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
Luvu Brands Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |